Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease

被引：643

作者：

Preische, Oliver ^{[1
,2
,3
]}

Schultz, Stephanie A. ^{[4
,5
]}

Apel, Anja ^{[1
,2
,3
]}

Kuhle, Jens ^{[6
,7
]}

Kaeser, Stephan A. ^{[1
,2
,3
]}

Barro, Christian ^{[6
,7
]}

Graeber, Susanne ^{[1
]}

Kuder-Buletta, Elke ^{[1
,42
]}

LaFougere, Christian ^{[1
]}

Laske, Christoph ^{[1
,2
,3
,42
]}

Voeglein, Jonathan ^{[8
,9
]}

Levin, Johannes ^{[8
,9
,40
]}

Masters, Colin L. ^{[10
]}

Martins, Ralph ^{[11
,12
,36
]}

Schofield, Peter R. ^{[13
,14
]}

Rossor, Martin N. ^{[15
]}

Graff-Radford, Neill R. ^{[16
]}

Salloway, Stephen ^{[17
,27
]}

Ghetti, Bernardino ^{[18
,19
,29
]}

Ringman, John M. ^{[20
]}

Noble, James M. ^{[21
]}

Chhatwal, Jasmeer ^{[22
,31
]}

Goate, Alison M. ^{[23
]}

Benzinger, Tammie L. S. ^{[4
,5
]}

Morris, John C. ^{[4
,5
]}

Bateman, Randall J. ^{[4
,5
]}

Wang, Guoqiao ^{[4
,5
]}

Fagan, Anne M. ^{[4
,5
]}

McDade, Eric M. ^{[4
,5
]}

Gordon, Brian A. ^{[4
,5
]}

Jucker, Mathias ^{[1
,2
,3
,42
]}

Allegri, Ricardo ^{[24
]}

Amtashar, Fatima ^{[25
]}

Bateman, Randall ^{[25
]}

Benzinger, Tammie ^{[25
]}

Berman, Sarah ^{[26
]}

Bodge, Courtney ^{[27
]}

Brandon, Susan ^{[25
]}

Brooks, William ^{[28
]}

Buck, Jill ^{[29
]}

Buckles, Virginia ^{[25
]}

Chea, Sochenda ^{[30
]}

Chhatwal, Jasmeer ^{[22
,31
]}

Chrem, Patricio ^{[24
]}

Chui, Helena ^{[32
]}

Cinco, Jake ^{[33
]}

Clifford, Jack ^{[30
]}

Cruchaga, Carlos ^{[25
]}

D'Mello, Mirelle ^{[28
]}

Donahue, Tamara ^{[25
]}

机构：

[1] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany

[2] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany

[3] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany

[4] Washington Univ, Sch Med, Dept Radiol, Dept Neurol, St Louis, MO 63110 USA

[5] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA

[6] Univ Basel, Neurol Clin & Policlin, Dept Med, Univ Hosp Basel, Basel, Switzerland

[7] Univ Basel, Neurol Clin & Policlin, Dept Biomed & Clin Res, Univ Hosp Basel, Basel, Switzerland

[8] German Ctr Neurodegenerat Dis DZNE, Munich, Germany

[9] Ludwig Maximilians Univ Munchen, Dept Neurol, Munich, Germany

[10] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Neurodegenerat Div, Parkville, Vic, Australia

[11] Edith Cowan Univ, Sch Med Hlth & Sci, Joondalup, WA, Australia

[12] Macquarie Univ, Dept Biomed Sci, Sydney, NSW, Australia

[13] Neurosci Res Australia, Randwick, NSW, Australia

[14] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia

[15] UCL, Queen Sq Inst Neurol, Dept Neurodegenerat, Dementia Res Ctr, London, England

[16] Mayo Clin Jacksonville, Dept Neurol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA

[17] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA

[18] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN 46202 USA

[19] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA

[20] USC, Keck Sch Med, Dept Neurol, Los Angeles, CA USA

[21] Columbia Univ, Med Ctr, Dept Neurol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA

[22] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA

[23] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA

[24] Inst Neurol Res, FLENI, Fdn Lucha Enfermedades Neurolog Infancia, Buenos Aires, DF, Argentina

[25] Washington Univ, Sch Med, St Louis, MO USA

[26] Univ Pittsburgh, Pittsburgh, PA USA

[27] Brown Univ, Butler Hosp, Providence, RI 02912 USA

[28] Neurosci Res Australia, Sydney, NSW, Australia

[29] Indiana Univ, Bloomington, IN USA

[30] Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA

[31] Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02114 USA

[32] Univ Southern Calif, Los Angeles, CA USA

[33] UCL, London, England

[34] Univ Calif San Diego, San Diego, CA 92103 USA

[35] Osaka City Univ, Osaka, Japan

[36] Edith Cowan Univ, Perth, WA, Australia

[37] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[38] Columbia Univ, New York, NY USA

[39] Hirosaki Univ, Aomori, Japan

[40] German Ctr Neurodegenerat Dis DZNE, Munich, Germany

[41] Niigata Univ, Niigata, Japan

[42] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany

[43] Univ Michigan, Ann Arbor, MI 48109 USA

[44] Asan Med Ctr, Seoul, South Korea

[45] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[46] Univ Melbourne, Melbourne, Vic, Australia

[47] Univ Tokyo, Tokyo, Japan

[48] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

NATURE MEDICINE | 2019年 / 25卷 / 02期

基金：

瑞士国家科学基金会; 美国国家卫生研究院; 美国国家科学基金会;

关键词：

AUTOSOMAL-DOMINANT; LIGHT-CHAIN; NEURONAL DAMAGE; BIOMARKER; PROTEIN; BLOOD; INDIVIDUALS; MARKER; ONSET; CSF;

D O I：

10.1038/s41591-018-0304-3

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly Inherited Alzheimer Network and ultrasensitive immunoassay technology to demonstrate that NfL levels in the cerebrospinal fluid (n = 187) and serum (n = 405) are correlated with one another and are elevated at the presymptomatic stages of familial Alzheimer's disease. Longitudinal, within-person analysis of serum NfL dynamics (n = 196) confirmed this elevation and further revealed that the rate of change of serum NfL could discriminate mutation carriers from non-mutation carriers almost a decade earlier than cross-sectional absolute NfL levels (that is, 16.2 versus 6.8 years before the estimated symptom onset). Serum NfL rate of change peaked in participants converting from the presymptomatic to the symptomatic stage and was associated with cortical thinning assessed by magnetic resonance imaging, but less so with amyloid-beta deposition or glucose metabolism (assessed by positron emission tomography). Serum NfL was predictive for both the rate of cortical thinning and cognitive changes assessed by the Mini-Mental State Examination and Logical Memory test. Thus, NfL dynamics in serum predict disease progression and brain neurodegeneration at the early presymptomatic stages of familial Alzheimer's disease, which supports its potential utility as a clinically useful biomarker.

引用

页码：277 / +

页数：17

共 46 条

[1] Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
Bacioglu, Mehtap
Maia, Luis F.
Preische, Oliver
Schelle, Juliane
Apel, Anja
Kaeser, Stephan A.
Schweighauser, Manuel
Eninger, Timo
Lambert, Marius
Pilotto, Andrea
Shimshek, Derya R.
Neumann, Ulf
Kahle, Philipp J.
Staufenbiel, Matthias
Neumann, Manuela
Maetzler, Walter
Kuhle, Jens
Jucker, Mathias
[J]. NEURON, 2016, 91 (01) : 56 - 66
[2] Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Barro, Christian
Benkert, Pascal
Disanto, Giulio
Tsagkas, Charidimos
Amann, Michael
Naegelin, Yvonne
Leppert, David
Gobbi, Claudio
Granziera, Cristina
Yaldizli, Ozgur
Michalak, Zuzanna
Wuerfel, Jens
Kappos, Ludwig
Parmar, Katrin
Kuhle, Jens
[J]. BRAIN, 2018, 141 : 2382 - 2391
[3] Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Bateman, Randall J.
Xiong, Chengjie
Benzinger, Tammie L. S.
Fagan, Anne M.
Goate, Alison
Fox, Nick C.
Marcus, Daniel S.
Cairns, Nigel J.
Xie, Xianyun
Blazey, Tyler M.
Holtzman, David M.
Santacruz, Anna
Buckles, Virginia
Oliver, Angela
Moulder, Krista
Aisen, Paul S.
Ghetti, Bernardino
Klunk, William E.
McDade, Eric
Martins, Ralph N.
Masters, Colin L.
Mayeux, Richard
Ringman, John M.
Rossor, Martin N.
Schofield, Peter R.
Sperling, Reisa A.
Salloway, Stephen
Morris, John C.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) : 795 - 804
[4] Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
Bateman, Randall J.
Aisen, Paul S.
De Strooper, Bart
Fox, Nick C.
Lemere, Cynthia A.
Ringman, John M.
Salloway, Stephen
Sperling, Reisa A.
Windisch, Manfred
Xiong, Chengjie
[J]. ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (01)
[5] Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
Benzinger, Tammie L. S.
Blazey, Tyler
Jack, Clifford R., Jr.
Koeppe, Robert A.
Su, Yi
Xiong, Chengjie
Raichle, Marcus E.
Snyder, Abraham Z.
Ances, Beau M.
Bateman, Randall J.
Cairns, Nigel J.
Fagan, Anne M.
Goate, Alison
Marcus, Daniel S.
Aisen, Paul S.
Christensen, Jon J.
Ercole, Lindsay
Hornbeck, Russ C.
Farrar, Angela M.
Aldea, Patricia
Jasielec, Mateusz S.
Owen, Christopher J.
Xie, Xianyun
Mayeux, Richard
Brickman, Adam
McDade, Eric
Klunk, William
Mathis, Chester A.
Ringman, John
Thompson, Paul M.
Ghetti, Bernardino
Saykin, Andrew J.
Sperling, Reisa A.
Johnson, Keith A.
Salloway, Stephen
Correia, Stephen
Schofield, Peter R.
Masters, Colin L.
Rowe, Christopher
Villemagne, Victor L.
Martins, Ralph
Ourselin, Sebastien
Rossor, Martin N.
Fox, Nick C.
Cash, David M.
Weiner, Michael W.
Holtzman, David M.
Buckles, Virginia D.
Moulder, Krista
Morris, John C.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (47) : E4502 - E4509
[6] NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration
Brureau, Anthony
Blanchard-Bregeon, Veronique
Pech, Catherine
Hamon, Stephanie
Chaillou, Pascal
Guillemot, Jean-Claude
Barneoud, Pascal
Bertrand, Philippe
Pradier, Laurent
Rooney, Thomas
Schussler, Nathalie
[J]. NEUROBIOLOGY OF DISEASE, 2017, 104 : 73 - 84
[7] Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
Burnham, Samantha C.
Bourgeat, Pierrick
Dore, Vincent
Savage, Greg
Brown, Belinda
Laws, Simon
Maruff, Paul
Salvado, Olivier
Ames, David
Martins, Ralph N.
Masters, Colin L.
Rowe, Christopher C.
Villemagne, Victor L.
[J]. LANCET NEUROLOGY, 2016, 15 (10) : 1044 - 1053
[8] Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
Byrne, Lauren M.
Rodrigues, Filipe B.
Blennow, Kaj
Durr, Alexandra
Leavitt, Blair R.
Roos, Raymund A. C.
Scahill, Rachael I.
Tabrizi, Sarah J.
Zetterberg, Henrik
Langbehn, Douglas
Wild, Edward J.
[J]. LANCET NEUROLOGY, 2017, 16 (08) : 601 - 609
[9] Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)
Cairns, Nigel J.
Perrin, Richard J.
Franklin, Erin E.
Carter, Deborah
Vincent, Benjamin
Xie, Mingqiang
Bateman, Randall J.
Benzinger, Tammie
Friedrichsen, Karl
Brooks, William S.
Halliday, Glenda M.
McLean, Catriona
Ghetti, Bernardino
Morris, John C.
[J]. NEUROPATHOLOGY, 2015, 35 (04) : 390 - 400
[10] Stan: A Probabilistic Programming Language
Carpenter, Bob
Gelman, Andrew
Hoffman, Matthew D.
Lee, Daniel
Goodrich, Ben
Betancourt, Michael
Brubaker, Marcus A.
Guo, Jiqiang
Li, Peter
Riddell, Allen
[J]. JOURNAL OF STATISTICAL SOFTWARE, 2017, 76 (01): : 1 - 29

← 1 2 3 4 5 →